"GLP-1 medications are intriguing from a cancer research perspective because they weren't designed for cancer therapy, but they do affect many different targets and pathways associated with cancer development, so we're eager to study them in this context," McDonald said
explores the interactions between beta-carotene/retinol and thyroid hormones, as well as the results of clinical trials investigating the relationship between beta-carotene intake and thyroid hormone levels
doi: 10.1042/CS20191032 46 ZhangMGaoMChenJSongLWeiW
Not surprisingly, people who have Type 2 diabetes, as well as those with higher incomes and fewer side effects, are more likely to stay on GLP-1s
J Neurochem 112(2):453462
Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies